Economic Structural Change and Cancer Incidence - An International Examination by Ferretti, F. & McIntosh, Bryan
 The University of Bradford Institutional 
Repository 
http://bradscholars.brad.ac.uk 
This work is made available online in accordance with publisher policies. Please refer to the 
repository record for this item and our Policy Document available from the repository home 
page for further information. 
To see the final version of this work please visit the publisher’s website. Available access to 
the published online version may require a subscription. 
Link to publisher’s version: http://dx.doi.org/10.12968/bjhc.2014.20.6.275 
Citation: Ferretti, F. and McIntosh, B. (2014). Economic Structural Change and Cancer Incidence - 
An International Examination. British Journal of Healthcare Management, 20 (6): 275-280. 
Copyright statement: © 2014 Mark Allen Group. Reproduced in accordance with the publisher's 
self-archiving policy. 
 
 
 
1 
Economic Structural Change and Cancer Incidence - An International Examination 
Dr Fabrizio Ferretti, School of Social Sciences, 
University of Modena and Reggio Emilia 
Dr Bryan McIntosh, Senior lecturer in health management and organisational behaviour, 
University of Bradford 
Abstract. 
After heart disease, cancer is the most common cause of death in many developed countries. In this 
paper, we discuss the relationship between economic growth and cancer incidence. The purposes 
of the paper are to describe and measure the influence of an increasing real per capita income on 
the overall incidence of cancer. Using cross-sectional data for 162 countries, regression results with 
crude and age-standardised rates allow us to measure the elasticity of cancer incidence with 
respect to per capita income, and to decompose the elasticity coefficient into two components: age-
effect and lifestyle-effect.  
Introduction 
In every human society, quality of life is an outcome of many different variables. Some of these 
variables, however, show a positive and significant correlation with per capita income, usually 
measured by the ratio of real gross national income (GNI) to population. This is why the real GNI 
per capita is often used as the first and basic indicator of standard of living. 
Health is a fundamental dimension of quality of life. In fact, almost all indices of economic and 
social well-being contain at least one variable for measuring health conditions. There are some 
important exceptions, but in the long-run, higher values of real per capita income usually 
correspond to better hygiene and sanitary conditions. During growth, however, each society 
undergoes several important changes in both demand and supply of health care. Thereby, the 
process of economic growth modifies the composition and order of importance of the main 
population health problems. 
Understanding and measuring how cancer incidence evolves during economic growth can be 
useful for forecasting the economic impact of cancer and for governing the process of resource 
allocation in planning health services. However, it is necessary to emphasise that this is not a study 
about social and economic factors causing cancerous diseases.  The purpose here is not to infer a 
causal relationship but to highlight some basic empirical regularities and theoretical insights to be 
considered for further research in order to develop an economic theory of cancer incidence. 
Basic measures of cancer frequency 
In order to describe and measure the frequency of cancerous diseases, epidemiology utilises three 
main indicators: incidence, prevalence and mortality. Incidence and mortality are flow variables, 
measured retrospectively. They indicate the number of new cancer cases and the number of deaths 
due to cancer, respectively, which occur in a specific population over a given period (usually 1 
year). Prevalence is a stock variable, measurable at one particular time point. It indicates the 
number of cancer cases in a specific population at a given point in time (Last, 2001). 
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Data on incidence, prevalence and mortality are usually expressed as absolute numbers or as rates. 
Rates can be crude or age-standardised. A crude rate is calculated by dividing the absolute number 
of new cases, cases or deaths by the corresponding number of people in the population at risk. An 
age-standardised rate is a weighted average of the age-specific crude rates, where the weights are 
the proportion of people in the corresponding age groups of a specific standard population. These 
age-adjusted rates are calculated to allow comparison between populations with different age 
structures, and they are particularly useful in making international comparisons. In this case, the 
most frequently used standard population is the world standard population (WHO, 2003) and the 
results are usually presented as annual rates per 100,000 persons at risk. 
 
Where raw data are regularly collected by local cancer registries, these basic measures of cancer 
frequency can be computed for each type of cancer, usually classified according to the 
International Classification of Diseases (ICD) or for all cancerous diseases as a whole (WHO, 2005). 
In this latter case, epidemiologists usually refer to the overall prevalence rate as a measure of 
society’s cancer burden. In the same way, since incidence is regarded as a useful approximation to 
the average risk of developing any type of cancer, the overall incidence rate is considered as an 
index of the level of cancer risk factors that exist in a given society, during a given period. Finally, 
the overall mortality rate provides an approximation to the average risk of dying from some type 
of cancer. 
 
International evidence 
 
Economic growth can affect cancer incidence, prevalence and mortality in various ways. In this 
paper we focus on the influence of a long-term increase in real per capita income on the overall 
incidence rate of all types of cancer. Using data from the World Bank (WB) and the World Health 
Organization (WHO), we develop an empirical analysis of the relationship between economic 
growth and cancer incidence. For this purpose, we use cross-sectional data on per capita income 
and cancer incidence in 2012, for 162 countries included in WB and WHO statistical databases, and 
for a subset of these 162 countries, which consist of a more homogeneous group of 41 countries, 
that are characterised by a “Western lifestyle”. In this subset there are 36 European countries plus 
Australia, Canada, New Zealand and the USA (from now, we simply refer to the whole set as the 
World group and to the subset as the Western group). 
 
Real per capita income is measured by the ratio of GNI to population and it is expressed in current 
international dollars, using purchasing power parity (PPP) rates (World Bank, 2007). Cancer 
incidence is measured by the crude and the age-standardised rates of all types of cancer (“all sites, 
but non melanoma skin”, according to the ICD classification) provided by the WHO within 
Globocan project (Bray et al., 2004). In fact, International Agency for Research on Cancer (IARC) 
publishes free software with worldwide estimation of cancer incidence, prevalence and mortality. 
For cancer incidence, these data include absolute numbers of new cancer cases, and crude and age-
standardised rates, in both the male and female population. 
 
This analysis, however, neglects the powerful influence of sex and age on cancer incidence. Thus, it 
is necessary to repeat OLS estimation using crude and age-standardised rates (ASR), in both the 
male and female populations (again in linear, quadratic and double-log specifications). Changes in 
per capita income, however, continue to explain an important part of the change in cancer 
incidence. This effect is not due to the positive influence of economic growth on the average 
duration of life. 
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In particular, a straight line best describes the relationship between real per capita income and 
cancer incidence within the female population in both groups of data, while quadratic and double-
log forms provide a reasonably close approximation to data for the male population in countries 
within the World and Western groups, respectively. All this seems to confirm a relevant negative 
effect of economic growth on the presence of cancer risk factors in different populations. 
 
Economic growth, structural change and cancer incidence 
 
At the microeconomic level, many studies have examined how personal income and wealth can 
influence individual exposure to cancer risk factors. On the contrary, macroeconomic analysis of 
this issue seems to be a relatively underdeveloped area of research. Previous studies in this field 
have highlighted that the evolution of cancer incidence in a growing economy is a very complex 
subject that should be approached in an interdisciplinary framework (Ukraintseva and Yashin, 
2005). To contribute to this aim, here, we develop a very basic economic model that can provide 
some insights into building a more realistic and complex theory (Bosanquet and Sikora, 2006). 
 
As in other stock–flow relationships, for a given average duration of the disease prevalence is a 
function of the incidence and mortality rates. In the following discussion, this kind of stock–flow 
relationship allows us to simply focus on cancer incidence and mortality, in order to develop an 
elementary framework where, ceteris paribus, changes in mortality and incidence rates during 
economic growth are primarily due to structural changes operating on the supply and demand 
sides of the economy, respectively. 
 
More particularly, on the supply side, as real GNI per capita income increases, better medical and 
surgical treatments become available, and notably, better techniques for early diagnosis and 
screening. All these technical changes can dramatically reduce cancer mortality. This is why, other 
things being equal, for a given incidence rate, economic growth implies a notable increase in 
prevalence rate (Capocaccia et al., 2002). In contrast, on the demand side of the economy, long-run 
increases in real per capita income tend to raise the average life expectation at birth. Since the 
average risk of developing any type of cancer is strongly influenced by age, economic growth may 
lead to an increase in the overall incidence rate of cancerous diseases. 
 
In this paper we focus only on the demand-side effects of economic growth on cancer incidence. 
Economic and social structural changes that characterise the processes of economic growth deeply 
modify the population’s habits and lifestyles. Studies on cancer aetiology point out the 
multifactorial nature of these types of diseases and the great importance of habits and lifestyles as 
risk factors (Nasca, 2007). As a result, economic growth tends to modify population exposure to 
cancer risk factors (such as nutritional and environmental risk factors). 
 
Considering these structural changes from the demand side of the economy, an Engel’s function 
may be a simple, but very useful tool for analysing how cancer incidence changes during economic 
growth. From this perspective, exposure to cancer risk factors can be thought as the consequence 
of the characteristics of goods and services that enter the average consumption bundle demanded 
by the representative consumer at each stages of economic growth. 
 
If there is something that we do positively know about expansion of per capita demand when real 
income increases, it is that per capita demand for each commodity usually does not increase 
proportionally (Pasinetti, 1981). This is a well-known generalisation of Engel’s law: it simply states 
that the proportion of income spent on each type of goods and services changes as real per capita 
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income increases, because consumers increase consumption along a hierarchy of needs. Therefore, 
during economic growth the composition of the average consumption bundle demanded by the 
representative consumer changes continually over time. 
 
For our purposes, it is useful to think of a consumption bundle of goods and services (QAC) that 
reflects a lifestyle characterised by a low risk of developing any type of cancerous diseases (i.e., an 
anti-cancer lifestyle). In the presence of a hierarchy of needs (determined by biological, cultural and 
social factors), even the demand for the QAC consumption bundle does not increase proportionally. 
With regard to how the demand for an anti-cancer lifestyle consumption bundle increases in a 
growing economy, it seems reasonable to introduce some basic hypotheses (Figure 1). In the early 
stages of economic growth, the demand for a healthy lifestyle is likely to be close to zero and it 
may tend to increase less than proportional with respect to real per capita income (Y). However, in 
the subsequent stages of growth, as real per capita income increases demand and income may be 
linearly related. After real per capita income reaches a threshold level (Y’’), the demand for an anti-
cancer lifestyle may tend to increases more than proportionally. 
 
Epidemiological data on tobacco consumption, for example, seems to support this hypothesis. In 
Figure 2, the age-standardised prevalence of current tobacco smoking among adults is plotted 
against the real per capita income. The scatter plot confirms that anti-cancer lifestyle behaves like a 
luxury good. At lower per capita income, economic growth pushes up tobacco consumption. 
Prevalence rate of current tobacco smoking is positive related to economic growth until about 
$15,000. After this threshold level, tobacco becomes an inferior good and the age-standardised 
prevalence of current tobacco smoking starts declining. 
 
From the Engel’s curve depicted in Figure 1, we can derive a function that describes how, ceteris 
paribus, the overall cancer incidence evolves in a growing economy. Figure 3 shows a possible 
general form of this relationship, in which cancer incidence is measured by the age-standardised 
rate (ASR) and economic growth is measured, again, by the real per capita income (Y). It is 
interesting to note that the relationship assumes the form of a type of Kuznets curve (Kuznets, 
1955). 
 
Increases in real per capita income have a more-than-proportional negative effect on the overall 
cancer incidence only in the early stages of economic growth. During growth, as a result of the 
expansion of demand for the anti-cancer lifestyle consumption bundle this more-than-proportional 
relationship tends to disappear. In particular, if a healthy lifestyle is a luxury good, after the early 
stages of economic growth the overall incidence rate will increase, but less than proportional with 
respect to Y (there also can be an interval of the growth process where the age-standardised rate of 
cancer incidence rises approximately linearly with per capita income). 
 
Furthermore, the relationship between overall cancer incidence and real per capita income has a 
positive intercept on the y-axis and a turning point. In particular, ASR° measures the autonomous 
component of the incidence rate (namely, the component that is independent of income, because it 
is weakly influenced by exposure to risk factors, such as in the type of cancer with an important 
genetic and/or infective aetiology) and Y* is the threshold level of per capita income beyond which 
cancer incidence starts diminishing.  
 
Conclusions 
 
Describing and measuring the relationship between cancer incidence and real per capita income 
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constitutes the first step in understanding how the process of economic growth affects population 
exposure to cancer causing factors.  
 
In fact, real per capita income is not an accurate and adequate measure of a country’s level of 
development and it is not possible to summarize in Y a set of economic, social and health features. 
Further research is needed to include more variables, as for example, those referring to personal 
income distribution, cultural habits and customs, general sanitary conditions and health policies. It 
is also necessary to utilise epidemiological data for each type of cancer within more homogeneous 
genetic populations. This paper, however, highlights some basic empirical regularities and 
theoretical insights that may be useful in developing an economic theory of the evolution of cancer 
incidence in a growing economy. 
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Figure 1 
Economic growth and Tobacco Consumption (118 countries WHO, 2005) 
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Figure 3 
 
